US 9382317
Stable aqueous formulations of adalimumab
granted A61KA61K2039/505A61K2039/542
Quick answer
US patent 9382317 (Stable aqueous formulations of adalimumab) held by Coherus BioSciences, Inc. expires Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Coherus BioSciences, Inc.
- Grant date
- Tue Jul 05 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 30 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61K2039/542, A61K2039/545, A61K39/39533